BioSig Technologies closes $15 million public offering

BioSig Technologies Inc. (NASDAQ: BSGM) completed a $15 million underwritten public offering on August 15, according to a company statement. The medical device company recently merged with Streamex Exchange Corporation, a gold tokenization infrastructure company.

The offering consisted of 3,852,149 shares of common stock priced at $3.90 per share. Gross proceeds totaled approximately $15,023,381 before deducting underwriter discounts, commissions and other offering expenses.

BioSig stated it plans to use net proceeds to purchase gold bullion in accordance with the company's investment policy, for general corporate purposes and working capital.

"We now have been able to marry a short and long-term capital strategy for the company with high-quality shareholders to support this pivotal point in our development," said Henry McPhie, CEO of BioSig and Co-Founder of Streamex. "We are building a Nasdaq-listed leader in the gold bullion based real world asset space and we can now focus on accelerated shareholder value creation."

Clear Street and Needham & Company served as joint book-running managers for the offering. The securities were offered through a shelf registration statement on Form S-3 that the Securities and Exchange Commission declared effective on December 17, 2024.

BioSig Technologies operates in the medical device sector with its PURE EP platform for electrophysiology procedures. Streamex, now a wholly owned subsidiary, focuses on gold tokenization and real world asset infrastructure.

You May Also Be Interested In

• Gores Holdings XI closes $358.8M IPO on Nasdaq
• FDA approves Pfizer's Ibrance for HR+, HER2+ metastatic breast cancer
• Identiv to sell IoT assets to Trackonomy for $50M in preferred equity